118 related articles for article (PubMed ID: 25236568)
1. Clinically relevant HOCl concentrations reduce clot retraction rate via the inhibition of energy production in platelet mitochondria.
Misztal T; Rusak T; Tomasiak M
Free Radic Res; 2014 Dec; 48(12):1443-53. PubMed ID: 25236568
[TBL] [Abstract][Full Text] [Related]
2. Peroxynitrite--altered platelet mitochondria--a new link between inflammation and hemostasis.
Misztal T; Przesław K; Rusak T; Tomasiak M
Thromb Res; 2013 Jan; 131(1):e17-25. PubMed ID: 23200902
[TBL] [Abstract][Full Text] [Related]
3. Peroxynitrite may affect clot retraction in human blood through the inhibition of platelet mitochondrial energy production.
Misztal T; Rusak T; Tomasiak M
Thromb Res; 2014 Mar; 133(3):402-11. PubMed ID: 24388569
[TBL] [Abstract][Full Text] [Related]
4. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.
Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T
Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970
[TBL] [Abstract][Full Text] [Related]
5. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.
Misztal T; Rusak T; Brańska-Januszewska J; Ostrowska H; Tomasiak M
Free Radic Biol Med; 2015 Dec; 89():533-47. PubMed ID: 26454084
[TBL] [Abstract][Full Text] [Related]
6. Serine/threonine phosphatases regulate platelet αIIbβ3 integrin receptor outside-in signaling mechanisms and clot retraction.
Moscardó A; Santos MT; Latorre A; Madrid I; Vallés J
Life Sci; 2013 Nov; 93(20):707-13. PubMed ID: 24096143
[TBL] [Abstract][Full Text] [Related]
7. Platelet-related fibrinolysis resistance in patients suffering from PV. Impact of clot retraction and isovolemic erythrocytapheresis.
Rusak T; Piszcz J; Misztal T; Brańska-Januszewska J; Tomasiak M
Thromb Res; 2014 Jul; 134(1):192-8. PubMed ID: 24824295
[TBL] [Abstract][Full Text] [Related]
8. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
Taylor FB; Müller-Eberhard HJ
J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
[TBL] [Abstract][Full Text] [Related]
9. Effects of prostaglandins, derivatives of cyclic 3':5'-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet-rich plasma and gel-separated platelet test systems.
Moake JL; Cimo PL; Widmer K; Peterson DM; Gum JR
Thromb Haemost; 1977 Aug; 38(2):420-8. PubMed ID: 202038
[TBL] [Abstract][Full Text] [Related]
10. Clot retraction is mediated by factor XIII-dependent fibrin-αIIbβ3-myosin axis in platelet sphingomyelin-rich membrane rafts.
Kasahara K; Kaneda M; Miki T; Iida K; Sekino-Suzuki N; Kawashima I; Suzuki H; Shimonaka M; Arai M; Ohno-Iwashita Y; Kojima S; Abe M; Kobayashi T; Okazaki T; Souri M; Ichinose A; Yamamoto N
Blood; 2013 Nov; 122(19):3340-8. PubMed ID: 24002447
[TBL] [Abstract][Full Text] [Related]
11. ADP, thrombin, and Bothrops atrox thrombinlike enzyme in platelet-dependent fibrin retraction.
Niewiarowski S; Stewart GJ; Nath N; Sha AT; Lieberman GE
Am J Physiol; 1975 Sep; 229(3):737-45. PubMed ID: 1211467
[TBL] [Abstract][Full Text] [Related]
12. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
13. Reduced clot retraction rate and altered platelet energy production in patients with asthma.
Tomasiak-Lozowska MM; Rusak T; Misztal T; Bodzenta-Lukaszyk A; Tomasiak M
J Asthma; 2016 Aug; 53(6):589-98. PubMed ID: 27145190
[TBL] [Abstract][Full Text] [Related]
14. Similarities between platelet contraction and cellular motility during mitosis: role of platelet microtubules in clot retraction.
Chao FC; Shepro D; Tullis JL; Belamarich FA; Curby WA
J Cell Sci; 1976 May; 20(3):569-88. PubMed ID: 1270531
[TBL] [Abstract][Full Text] [Related]
15. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR
Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041
[TBL] [Abstract][Full Text] [Related]
16. Peroxynitrite can affect platelet responses by inhibiting energy production.
Rusak T; Tomasiak M; Ciborowski M
Acta Biochim Pol; 2006; 53(4):769-76. PubMed ID: 17068635
[TBL] [Abstract][Full Text] [Related]
17. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.
Di Minno G; Cerbone AM; Mattioli PL; Turco S; Iovine C; Mancini M
J Clin Invest; 1985 Feb; 75(2):328-38. PubMed ID: 3156146
[TBL] [Abstract][Full Text] [Related]
18. Clot retraction: evaluation in dilute suspensions of platelet-rich plasma and gel-separated platelets.
Widmer K; Moake JL; Kent CJ; Yeo YY; Reynolds JP
J Lab Clin Med; 1976 Jan; 87(1):49-57. PubMed ID: 1245783
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of fibrin gel clot retraction by platelets and cultured tumor cells.
Tanoue K; Katagiri Y; Suzuki H
Pol J Pharmacol; 1996; 48(3):341-3. PubMed ID: 9112674
[TBL] [Abstract][Full Text] [Related]
20. Platelet microtubules in clot structure formation and contractile force generation: investigation of a controversy.
Jen CJ; McIntire LV
Thromb Haemost; 1986 Aug; 56(1):23-7. PubMed ID: 2877507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
